A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

April 17, 2024

Study Completion Date

October 1, 2024

Conditions
Diabetic Macular Edema
Interventions
DRUG

Vamikibart

Vamikibart will be administered by IVT injection in the study eye.

DRUG

Ranibizumab

Ranibizumab will be administered by IVT injection in the study eye.

OTHER

Sham Procedure

Sham is a procedure that mimics an IVT injection and involves the blunt end of an empty syringe (without a needle) being pressed against the anesthetized eye.

Trial Locations (38)

21740

Cumberland Valley Retina Consultants, Hagerstown

28027

Clinica Universitaria de Navarra, Madrid

31008

Clinica Universitaria de Navarra, Pamplona

33617

Retina Vitreous Associates of Florida, Tampa

38671

Deep Blue Retina PLLC, Southaven

42415

Yeungnam University Medical Center, Daegu

49241

Pusan National University Hospital, Busan

76012

Texas Retina Associates, Arlington

77401

Retina Consultants of Texas, Bellaire

90502

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance

91006

Win Retina, Arcadia

94598

Bay Area Retina Associates, Walnut Creek

97401

Verum Research LLC, Eugene

3109601

Rambam Medical Center, Haifa

4941492

Rabin MC, Petah Tikva

6423906

Tel Aviv Sourasky MC, Tel Aviv

7660101

Kaplan Medical Center, Rehovot

9112001

Hadassah MC, Jerusalem

30394-7344

Florida Eye Associates, Melbourne

C1015ABO

Organizacion Medica de Investigacion, Buenos Aires

C1116

Centro Oftalmológico Dr. Charles S.A., Capital Federal

C1120AAN

Oftalmos, Capital Federal

C1061AAE

Buenos Aires Mácula, Ciudad Autonoma Buenos Aires

S2000DLA

Grupo Laser Vision, Rosario

K2B 7E9

Retina Institute of Ottawa, Ottawa

M3C 0G9

Toronto Retina Institute, Toronto

J7H 0E8

Institut De L'Oeil Des Laurentides, Boisbriand

44-100

Niepubliczny Zak?ad Opieki Zdrowotnej PRYZMAT-OKULISTYKA, Gliwice

31-070

Centrum Medyczne UNO-MED, Krakow

10-424

Centrum Diagnostyki i Mikrochirurgii Oka LENS, Olsztyn

42-600

Caminomed, Tarnowskie Góry

00613

Emanuelli Research and Development Center LLC, Arecibo

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

07301

Kim's Eye Hospital, Seoul

GL1 3NN

Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire

GU2 7XX

Royal Surrey County Hospital, Guildford

SE5 9RS

Kings College Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT05151744 - A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter